Tyme Technologies Inc. (TYME)

[mcsharkey]

Well nuts,
Today's telecon/10Q kind of an abbreviated rehash. Not close to expansion of programs I was hoping for.

It did shed light on our collaboration with EVOTECH, largely a European bio tech, and use of biomarkers vs. PET scans (e.g. Invasive Circulating Tumor Cells (iCTCs) ) in monitoring clinical effect of therapies.
With my first notice of EVOTECH collaboration.

Question arises on whether our SM-88 may be in used over in European Clinical Trials, coincidentally, EVOTECH is having their own investor meeting tomorrow:

(11 August 2021 Half-year 2021 Interim Report and webcast, https://www.evotec.com/en/invest/investor-relations-events).[/quote]
On to the 24th of August, and our proxy vote. Hope for me was today's meeting would add a ballot item onto the existing ballot. Didn't happen.

Cash Burn rate only investable news today,
IMHO
GLTUA

Evotec A.G.
Biotechnology company

evotec.com
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. Wikipedia
Stock price: EVTCY (OTCMKTS) $86.75 0.00 (0.00%)
Aug 6, 3:17 PM EDT - Disclaimer
Revenue: 446.4 million EUR (2019)
Headquarters: Hamburg, Germany
Founder: Manfred Eigen
Founded: 1993
Number of employees: 3,030 (2020)